Results 271 to 280 of about 7,440,138 (398)
New Drug Approvals in China: An International Comparative Analysis, 2019-2023. [PDF]
Yan Y+7 more
europepmc +1 more source
Should the drug industry work with key opinion leaders? Yes [PDF]
Charlie Buckwell
openalex +1 more source
Abstract Background Dual‐energy cone‐beam CT (DE‐CBCT) has become subject of recent interest due to the ability to produce virtual monoenergetic images (VMIs) with improved soft‐tissue contrast and reduced nonuniformity artifacts. However, efficient production and optimization of VMIs remains an under‐explored part of DE‐CBCT's application.
Andrew Keeler+4 more
wiley +1 more source
Breaking barriers: we need a multidisciplinary approach to tackle cancer drug resistance. [PDF]
Ingham J, Ruan JL, Coelho MA.
europepmc +1 more source
Defining Molecular Targets for Drug Design: Synergism Between Academia and Industry
Andrew C. Chan
openalex +1 more source
NIMH Initiatives to Facilitate Collaborations Among Industry, Academia, and Government for the Discovery and Clinical Testing of Novel Models and Drugs for Psychiatric Disorders [PDF]
Linda S. Brady+4 more
openalex +1 more source
Abstract Purpose Breast cancer is a neoplastic disease with high prevalence among women. Radiotherapy is one of the principal treatment modalities for this disease, but it poses significant challenges. This study aimed to compare and evaluate the technical and dosimetric performance of conventional C‐arm linac systems and a new design, Halcyon, in the ...
Mustafa Çağlar+8 more
wiley +1 more source
Prevalence of pharmaceutical industry conspiracy theories among the polish population. [PDF]
Makowska M, Ozaki A, Boguszewski R.
europepmc +1 more source